He has been the President of Jack Levine, PA, a certified public accounting firm since 1984, advising corporations on financial and accounting matters and serving as an independent director on numerous boards. Mr. Levine is currently a director and chairman of the audit committee of SignPath Pharma, Inc., a development-stage biotechnology company, since 2010. Mr. Levine’s previous board memberships included Provista Diagnostics, Inc., from 2011 to 2018; Biscayne Pharmaceuticals, Inc., from 2004 to 2008 and Pharmanet, Inc., from 1999 to 2007. Mr. Levine received a B.A. degree from Hunter College of the City University of New York and an M.A. from New York University.